# IZ Clinical Notes Analyzer Remediation Report - 2026-06-26

## Summary

This remediation pass hardened the local-first clinical notes analyzer across the Alleva/API readiness harness, treatment-plan completeness and timeliness workflow, PHI minimization, audit logging, encrypted local storage, manager review/export surfaces, Windows launch paths, and operator documentation.

The follow-up Codex Security standard scan `9776b900-4f2d-4131-bdc8-14550c6a23dd` completed with `0` reportable findings against revision `123feab324a8406c401f5dc4e93c686b28419efb`.

## Completed Hardening

- Centralized Alleva retrieval, pagination, ID mapping, partial-result handling, and redacted diagnostics in the backend service layer.
- Preserved live Alleva treatment-plan sync as gated by explicit approval and mapping readiness.
- Tightened API harness responses so saved credentials, raw vendor material, PHI-like payloads, and response samples are redacted before browser or audit exposure.
- Reinforced RBAC/object scoping for timeliness, chart, note-set, review-source, and manager/admin workflows.
- Reduced PHI exposure by generating safe upload labels and download filenames, sanitizing rule evidence, and avoiding raw uploaded-note text in logs and exports.
- Kept deterministic treatment-plan outcomes for missing, conflicting, incomplete, or unvalidated evidence rather than guessing compliance.
- Hardened CSV/HTML report exports against formula and markup injection.
- Updated Windows launcher, installer, smoke, diagnostics, and local admin recovery scripts for safer local startup and support collection.
- Updated operator/developer docs, open blockers, release notes, and sample-data guidance with synthetic-data and LOC-change caveats.

## Validation Evidence

- Backend pytest: `118 passed, 2 skipped, 1 warning`.
- Frontend Vitest: `17 passed`.
- Frontend production build: passed.
- Browser smoke against disposable local app with synthetic data only: passed.
- Codex Security follow-up scan: completed, `0` reportable findings.

## Residual Notes

- Codex Security coverage is marked `partial` because delegated discovery workers were unavailable after a runtime usage-limit warning. The parent-agent review closed 18 high-risk surfaces with no surviving findings; a later delegated pass can reduce residual broad-inventory uncertainty.
- The level-of-care treatment-plan update window remains an unvalidated R3/Marleigh business-rule blocker and must remain configurable and documented until confirmed.
- Live Alleva production import remains blocked pending official R3/Alleva approval, tenant credentials, endpoint mapping, authentication requirements, pagination, rate limits, attachment behavior, vendor documentation, and compliance approval.
